Medexus Pharmaceuticals
(OTC) MEDXF
Medexus Pharmaceuticals Financials at a Glance
Market Cap
$73.71M
Revenue (TTM)
$99.43M
Net Income (TTM)
$272.00K
EPS (TTM)
$-0.01
P/E Ratio
-201.95
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$2.30
Volume
7,669
Open
$2.25
Price
$2.30
Volume
7,669
Open
$2.25
Previous Close
$2.30
Daily Range
$2.25 - $2.35
52-Week Range
$1.43 - $2.62
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$2.30
Volume
7,669
Open
$2.25
Previous Close
$2.30
Daily Range
$2.25 - $2.35
52-Week Range
$1.43 - $2.62
MEDXF News
MEDXF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Medexus Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
91
CEO
Kenneth d’Entremont
Website
www.medexusinc.comHeadquarters
Bolton, ON L7E 1K1, CA
MEDXF Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
3%
Net Income Margin
-0%
Return on Equity
-64%
Return on Capital
4%
Return on Assets
-0%
Earnings Yield
-0.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$73.71M
Shares Outstanding
32.30M
Volume
7.67K
Short Interest
0.00%
Avg. Volume
14.38K
Financials (TTM)
Gross Profit
$56.58M
Operating Income
$8.22M
EBITDA
$16.81M
Operating Cash Flow
$24.03M
Capital Expenditure
$2.73M
Free Cash Flow
$21.31M
Cash & ST Invst.
$23.97M
Total Debt
$37.18M
Medexus Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$25.32M
-15.6%
Gross Profit
$13.58M
-10.6%
Gross Margin
53.62%
N/A
Market Cap
$73.71M
N/A
Market Cap/Employee
$898.90K
N/A
Employees
82
N/A
Net Income
$80.00K
-89.1%
EBITDA
$5.71M
+23.3%
Quarterly Fundamentals
Net Cash
$10.38M
+67.0%
Accounts Receivable
$11.83M
-16.3%
Inventory
$31.30M
-8.0%
Long Term Debt
$18.15M
-18.1%
Short Term Debt
$7.20M
-59.4%
Return on Assets
-0.16%
N/A
Return on Invested Capital
3.67%
N/A
Free Cash Flow
$7.81M
+18.3%
Operating Cash Flow
$7.83M
+16.7%